Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Q4 2025 Earnings Call January 22, 2026 5:00 PM ESTCompany ParticipantsJohn Pitzer - Corporate Vice President of Corporate ...
We asked certified financial planners, investment advisers and other money experts their thoughts on stock choices this year ...
Intel Corporation (NASDAQ:INTC) Q4 2025 Earnings Call Transcript January 22, 2026 Intel Corporation beats earnings ...
While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...
Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...
Over the last 10 months, we established the foundation for new Intel, a more focus and execution-driven company. Along with ...
Opinion
AI's promise, biotech's peril: How unequal access to computing power threatens medical breakthroughs
One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The other, to a landscape where breakthroughs regularly ...
Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Executives from Recursion (Nasdaq: RXRX), a leading clinical stage TechBio ...
Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial consultant. She has a demonstrated history of working in both institutional and retail environments, from broker-dealers to ...
Have you ever phoned up a company and had your call held in a queue? Could AI make this less painful? Pippa and Phil discuss this and teach you some new vocabulary. Hello. Your call is important to us ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results